This meeting will be in CLOSED session on Monday, February 4th.
Please note that the OPEN session for this meeting will be on
Tuesday, February 5th from 10:30am to 2:15pm
Monday, February 4
Time
Activity
Speaker
8:30 – 8:45
Welcome – Opening Remarks
Al Berg
8:45 – 9:00
Status Updates
David Dotson
9:00 – 12:00
Presentation and Discussion of The EGAPP
Supplementary Evidence Review: DNA testing
strategies Aimed at Reducing Morbidity and Morality from Lynch Syndrome
Discussion of the Draft Recommendation Statement
Technical Consultants & WG Members
12:00 – 1:00
Lunch
Guest Speaker
Cecile Janssens, PhD, Erasmus Medical Center, Rotterdam, NL
1:00 – 2:30
Breakout Sessions
Breast Cancer Recommendation
UGT1A1 Report and Recommendation Statement
WG Members & Consultants
2:30 – 3:00
Report and Discussion on Breakout Session I
WG Members & Consultants
3:00 – 3:15
Break
3:15 – 3:45
Report and Discussion on Breakout Session II
WG Members & Consultants
3:45 – 4:45
Discussion and Planning for Evidence Review for Genetic Testing for Risk of Cardiovascular Disease
WG Members & Consultants
4:45 – 5:00
Wrap-up and Adjourn Closed Session
Al Berg
Tuesday, February 5
Time
Activity
Speaker
7:30 – 9:00
Executive Session – Working Group Members only
Al Berg & Staff
9:00 – 10:00
Subcommittee Meetings
Methods
Topics
Products
Steve Teutsch, chair
Joan Scott, chair
Celia Kaye, chair
10:00 – 10:30
Break
10:30 – 11:00
Open session called to order
Overview of Day 1, brief staff updates and outstanding questions
Al Berg & Staff
11:00 – 11:30
EGAPP Stakeholders Group (ESG) Report
Debra Leonard, chair
11:30 – 12:15
Topics Subcommittee Report
Joan Scott
12:15 – 12:30
Public Comment
12:30 – 1:15
Working Lunch
Methods Subcommittee Report
Steve Teutsch
1:15 – 2:00
Products Subcommittee Report
Celia Kaye
2:00 – 2:15
Wrap-up and Action Items
Al Berg & Linda Bradley
2:15
Adjourn
Page last reviewed: October 12, 2013 (archived document)
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.